Amgen launches $1 bln senior notes in 2 parts – IFR – Reuters
By admin
|
Amgen launches $1 bln senior notes in 2 parts – IFR
Reuters O), the world's largest biotechnology company, on Tuesday launched a $1 billion two-part sale, said IFR, a Thomson Reuters service. … Amgen Inc to sell $1 bln sr notes in two parts-IFRInteractive Investor |
March 9th, 2010
This author published 9263 posts in this site.Share
You must be logged in to send a comment.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research